At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.
Having identified a gap in the market for safe and gentle earwax removal services in her local community, Lisa started Earworx as a part-time venture alongside her role at the Royal Hobart Hospital. Over time, the business grew, and she transitioned to running it full-time, overcoming various challenges along the way, including the impact of COVID-19 and navigating the regulatory environment.
The recognition received at the Telstra Best of Business Award was a meaningful validation of Earworx’s efforts. It not only bolstered the business’s already strong reputation but also provided a boost to its branding, according to Hellwege.
Describing the rigorous application process, including extensive submissions and nerve-wracking presentations, Hellwege acknowledged that it provided invaluable insights into their own business.
Looking ahead, Earworx aims to raise awareness about the vital role of registered nurses in supporting the Australian healthcare system and addressing its challenges. The business plans to continue its mission of delivering high-quality, nurse-led earwax removal services while advocating for recognition and support from funding bodies.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
The 2019 John Deeble Lecture and Panel Discussion
The John Deeble Lecture and Panel Discussion was established by the Australian Healthcare and Hospitals Association to commemorate the life and achievements as distinguished scholar, health economist and health policy leader, Prof John Deeble AO.
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
